Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
2.630
+0.080 (3.14%)
Dec 20, 2024, 4:00 PM EST - Market closed
Sonoma Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 4.08 | 3.13 | 3.82 | 7.4 | 4.22 | 3.69 | Upgrade
|
Cash & Short-Term Investments | 4.08 | 3.13 | 3.82 | 7.4 | 4.22 | 3.69 | Upgrade
|
Cash Growth | 90.83% | -18.12% | -48.35% | 75.26% | 14.33% | 0.05% | Upgrade
|
Accounts Receivable | 3.16 | 2.9 | 2.57 | 2.41 | 2.81 | 3.97 | Upgrade
|
Other Receivables | 0.22 | 0.26 | 0.24 | 0.22 | 0.21 | 0.18 | Upgrade
|
Receivables | 3.38 | 3.16 | 2.81 | 2.63 | 3.02 | 4.16 | Upgrade
|
Inventory | 2.84 | 2.72 | 2.86 | 2.66 | 2.53 | 2.18 | Upgrade
|
Prepaid Expenses | 1.93 | 3.54 | 4.31 | 3.75 | 3.22 | 2.26 | Upgrade
|
Total Current Assets | 12.22 | 12.55 | 13.8 | 16.43 | 12.98 | 12.28 | Upgrade
|
Property, Plant & Equipment | 0.42 | 0.65 | 0.91 | 0.88 | 1.13 | 0.72 | Upgrade
|
Long-Term Deferred Tax Assets | 0.79 | 1.15 | 0.95 | 0.83 | - | - | Upgrade
|
Other Long-Term Assets | 0.26 | 0.4 | 0.58 | 0.71 | 0.88 | 1.55 | Upgrade
|
Total Assets | 13.69 | 14.74 | 16.23 | 18.85 | 14.99 | 14.56 | Upgrade
|
Accounts Payable | 0.77 | 0.61 | 0.84 | 1.64 | 1.77 | 2.07 | Upgrade
|
Accrued Expenses | 2.02 | 1.42 | 1.46 | 1.06 | 0.79 | 1.31 | Upgrade
|
Short-Term Debt | 0.08 | 0.32 | 0.43 | 0.69 | 0.6 | - | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | 0.12 | - | 0.48 | Upgrade
|
Current Portion of Leases | 0.12 | 0.2 | 0.26 | 0.25 | 0.24 | 0.13 | Upgrade
|
Current Unearned Revenue | 0.32 | 0.48 | 0.16 | 1.28 | 0.32 | 0.27 | Upgrade
|
Other Current Liabilities | - | 0.69 | 0.57 | 0.78 | 0.37 | 0.46 | Upgrade
|
Total Current Liabilities | 3.31 | 3.72 | 3.72 | 5.82 | 4.08 | 4.73 | Upgrade
|
Long-Term Debt | - | - | - | - | 1.31 | - | Upgrade
|
Long-Term Leases | 0.05 | 0.09 | 0.16 | 0.31 | 0.53 | 0.24 | Upgrade
|
Long-Term Unearned Revenue | 0.05 | 0.09 | 0.14 | 0.18 | 0.23 | 0.25 | Upgrade
|
Other Long-Term Liabilities | 4.93 | 4.71 | 4.24 | 3.84 | 3.48 | 3.73 | Upgrade
|
Total Liabilities | 8.33 | 8.6 | 8.25 | 10.15 | 9.62 | 8.94 | Upgrade
|
Common Stock | - | 0 | 0.01 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 205.65 | 203.21 | 200.9 | 197.37 | 189.22 | 186.56 | Upgrade
|
Retained Earnings | -196.1 | -194.35 | -189.51 | -184.36 | -179.28 | -175.33 | Upgrade
|
Comprehensive Income & Other | -4.2 | -2.72 | -3.42 | -4.31 | -4.58 | -5.61 | Upgrade
|
Shareholders' Equity | 5.35 | 6.14 | 7.98 | 8.7 | 5.36 | 5.62 | Upgrade
|
Total Liabilities & Equity | 13.69 | 14.74 | 16.23 | 18.85 | 14.99 | 14.56 | Upgrade
|
Total Debt | 0.24 | 0.61 | 0.85 | 1.37 | 2.68 | 0.85 | Upgrade
|
Net Cash (Debt) | 3.83 | 2.52 | 2.97 | 6.03 | 1.55 | 2.84 | Upgrade
|
Net Cash Growth | 137.40% | -15.18% | -50.72% | 290.23% | -45.62% | -11.61% | Upgrade
|
Net Cash Per Share | 4.80 | 5.54 | 17.51 | 45.45 | 15.48 | 38.47 | Upgrade
|
Filing Date Shares Outstanding | 1.34 | 0.94 | 0.25 | 0.16 | 0.1 | 0.1 | Upgrade
|
Total Common Shares Outstanding | 1.34 | 0.78 | 0.25 | 0.16 | 0.1 | 0.09 | Upgrade
|
Working Capital | 8.91 | 8.83 | 10.08 | 10.61 | 8.91 | 7.55 | Upgrade
|
Book Value Per Share | 4.00 | 7.86 | 32.34 | 56.09 | 51.25 | 63.28 | Upgrade
|
Tangible Book Value | 5.35 | 6.14 | 7.98 | 8.7 | 5.36 | 5.62 | Upgrade
|
Tangible Book Value Per Share | 4.00 | 7.86 | 32.34 | 56.09 | 51.25 | 63.28 | Upgrade
|
Machinery | - | 2.14 | 1.95 | 1.53 | 1.35 | 3.49 | Upgrade
|
Leasehold Improvements | - | 0.61 | 0.55 | 0.5 | 0.49 | 0.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.